Burning Rock Biotech Files 6-K with AGM Notices

Ticker: BNR · Form: 6-K · Filed: Dec 3, 2024 · CIK: 1792267

Sentiment: neutral

Topics: agm, corporate-governance, filing

TL;DR

Burning Rock Biotech filed a 6-K with AGM docs, nothing major but check the press release.

AI Summary

Burning Rock Biotech Limited filed a Form 6-K on December 3, 2024, for the month of December 2024. The filing includes a press release, notice of the Annual General Meeting, and related proxy and voting card forms for ADS holders. The company's principal executive offices are located at No. 5 Xingdao Ring Road North, International Bio Island, Guangzhou, Guangdong, People's Republic of China.

Why It Matters

This filing indicates routine corporate governance activities, including the scheduling of an Annual General Meeting, which is important for shareholder engagement and company oversight.

Risk Assessment

Risk Level: low — The filing is a routine report of foreign private issuer and does not contain significant financial or operational news.

Key Players & Entities

FAQ

What is the purpose of this Form 6-K filing?

The Form 6-K is a report of foreign private issuer filed for the month of December 2024, containing routine corporate documents.

What documents are included in the Exhibit Index?

The Exhibit Index includes a press release (99.1), Notice of Annual General Meeting (99.2), Form of Proxy for the Annual General Meeting (99.3), and Form of Voting Card for ADS Holders (99.4).

Where are Burning Rock Biotech Limited's principal executive offices located?

The principal executive offices are located at No. 5 Xingdao Ring Road North, International Bio Island, Guangzhou, Guangdong, People's Republic of China.

Does Burning Rock Biotech file annual reports under Form 20-F or 40-F?

Burning Rock Biotech indicates that it files annual reports under Form 20-F.

What is the Commission File Number for this filing?

The Commission File Number for this filing is 001-39316.

Filing Stats: 171 words · 1 min read · ~1 pages · Grade level 11 · Accepted 2024-12-03 16:01:26

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Burning Rock Biotech Limited By: /s/ Yusheng Han Name: Yusheng Han Title: Chief Executive Officer Date: December 3, 2024

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing